656
Views
0
CrossRef citations to date
0
Altmetric
Original Articles: Cancer Epidemiology

Cancer-related costs should be allocated in a comparable way—benchmarking costs of cancer in Nordic countries 2012–2017

, , , &
Pages 1216-1222 | Received 05 Aug 2022, Accepted 12 Sep 2022, Published online: 24 Sep 2022

Figures & data

Table 1. Total costs of cancer care, individual cost drivers, costs per population and per incidence, and share of total healthcare expenditure in 2017.

Figure 1. (A) Development of costs of cancer care in real terms between 2012 and 2017 (indexed, 2012 = 100) and (b) development of cancer care costs per incidence (=number of new cancer patients each year), in real terms (indexed, 2012 = 100).

Figure 1. (A) Development of costs of cancer care in real terms between 2012 and 2017 (indexed, 2012 = 100) and (b) development of cancer care costs per incidence (=number of new cancer patients each year), in real terms (indexed, 2012 = 100).

Figure 2. Development of individual cost drivers in real terms in each country between 2012 and 2017 (indexed, 2012 = 100).

Figure 2. Development of individual cost drivers in real terms in each country between 2012 and 2017 (indexed, 2012 = 100).

Figure 3. Development of secondary care inpatient days and inpatient days per incidence (=number of new cancer patients each year), between in each country 2012 and 2017 (indexed, 2012 = 100).

Figure 3. Development of secondary care inpatient days and inpatient days per incidence (=number of new cancer patients each year), between in each country 2012 and 2017 (indexed, 2012 = 100).

Figure 4. Development of age-standardized cancer mortality rate in each country (deaths per 100,000 inhabitants) between 2012 and 2019.

Figure 4. Development of age-standardized cancer mortality rate in each country (deaths per 100,000 inhabitants) between 2012 and 2019.
Supplemental material

Supplemental Material

Download MS Word (16.1 KB)

Data availability statement

The data are available upon request from the corresponding author

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.